https://www.fool.com/investing/high-growth/2011/01/28/orexigens-contrave-an-obesity-drug-timeline.aspx
https://www.fool.com/investing/general/2011/11/18/astrazeneca-wins-ema-backing-for-thyroid-cancer-dr.aspx
